Search Results
Community Perspectives on Acute Myeloid Leukemia and Higher-Risk Myelodysplastic Syndrome
High Risk MDS Treatment Strategies
Low-Risk and High-Risk MDS
Venetoclax in Higher-Risk MDS/AML
Higher-Risk Myelodysplastic Syndromes | Inside the Issue: Novel Agents, Approaches and Strategies...
MPN Transformation to MDS and AML: Risk Factors, Therapy, and Outcomes
Treatment Update: Myelodysplastic Syndromes (MDS)
What’s on the horizon for higher-risk MDS? An update on emerging novel agents?
Expert Perspectives: MPN and MDS
Can we do better than HMA in HR-MDS?
“Intensity” With Efficacy in AML: Intensive Upfront Platforms
Transplantation for Myelodysplastic Syndromes (MDS): Who, When and How 2021
